A new prognostic scoring tool accurately assessed 30-day mortality risk in patients with alcohol-associated hepatitis, according to a study published in Mayo Clinic Proceedings.
“Prognostic modeling is becoming increasingly intertwined into an emerging yet controversial topic in the field of hepatology, including whether patients with severe [alcohol-associated hepatitis (AH)] should receive early liver transplants,” Camille A. Kezer, MD, of the department of internal medicine at the Mayo Clinic, and colleagues wrote. “This clinical and ethical predicament highlights why a